Vicore Pharma

Vicore Pharma operates within the development of pharmaceuticals. The company own patented substances designed to have an effect within the Renin Angiotensin System (RAS). RAS is a central hormone system, which can be essential for among other regulation of blood pressure. Today it is common that the system causes damage due to chronic activity.

Vicores substances contributes to the healing of damaged organs through resisting inflammation and repairing damaged cells by stimulating a receptor within the system, the so called AT2 receptor. One of the patented substances, “Compound 21” or “C21” have shown beneficial results in chemical analysis and animaltests and has therefore been choosen for intensified developmental efforts.  

Vicore Pharmas businessidea is to exploit the commercial possibilities offered through establishing new pharmaceutical molecules who selectively stimulates the so called AT2 receptor within the RAS system

Mintage Scientific owns 100% of Vicore Pharma AB.

To Vicore Pharma homepage >>